The DOI matches its Crossref record; 2 of the 2 references it cites were found in a registry or an index.
Compliance therapy: a randomised controlled trial in schizophrenia
Open accessAbstract
>Objective To evaluate the efficacy of “compliance therapy” for improving adherence to prescribed drug treatment among patients with schizophrenia. Design Randomised controlled trial. Setting Urban catchment area psychiatric service. Participants 94 consecutive admissions of patients with schizophrenia, 56 agreed to participate. Intervention Compliance therapy and non-specific counselling, each consisting of 5 sessions lasting 30-60 minutes. Main outcome measures Compliance with drug treatment at one year; attitudes to treatment, symptomatology, insight, and quality of life at one year; length of “survival” in the community, bed days, and rehospitalisation rates at two years. Results Compliance therapy did not confer a major advantage over non-specific therapy in improving compliance at one year (43% (12/28) v 54% (15/28), difference −11% (95% confidence interval −37% to 15%) or in any of the secondary outcome measures—symptomatology, attitudes to treatment, insight, global assessment of functioning, and quality of life. Conclusion Compliance therapy may not be of benefit to patients with schizophrenia. Attitudes to treatment at baseline predicted adherence one year later and may be a clinically useful tool.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The Positive and Negative Syndrome Scale (PANSS) for schizophrenia.
Kay, S. R., Fiszbein, A., & Opler, L. A. (1987) · Schizophrenia Bulletin · doi:10.1093/schbul/13.2.261 · Cited by 21,378
The Global Assessment Scale: A Procedure for Measuring Overall Severity of Psychiatric Disturbance
Endicott, J. (1976) · Archives of General Psychiatry · doi:10.1001/archpsyc.1976.01770060086012 · Cited by 4,982
Research works printed but not linked: 18
- Lewis, 1996, Biological predictors of suicidality in schizophrenia., Acta Psychiatr Scand, 94, 416, 10.1111/j.1600-0447.1996.tb09883.x · DOI
- 10.1097/00005053-199309000-00005 · DOI
- Fenton, 1997, Determinants of medication compliance in schizophrenia: empirical and clinical findings., Schizophr Bull, 23, 637, 10.1093/schbul/23.4.637 · DOI · Paper page
- 10.1176/appi.ps.52.2.161 · DOI
- 10.1136/bmj.312.7027.345 · DOI · Paper page
- 10.1192/bjp.172.5.413 · DOI · Paper page
- American Psychiatric Association . Structured clinical interview for the DSM-III-R. Washington DC: American Psychiatric Press, 1992.
- 10.1017/S0033291700050182 · DOI · Paper page
- 10.1192/bjp.156.6.798 · DOI · Paper page
- Heinrichs, 1984, The quality of life scale: an instrument for rating the schizophrenic deficit syndrome., Schizophr Bull, 10, 338, 10.1093/schbul/10.3.388 · DOI · Paper page
- Rollnick, 1993, Methods of helping patients with behaviour change., BMJ, 307, 188, 10.1136/bmj.307.6897.188 · DOI · Paper page
- John, 1994, Cognitive-behavioural therapy for schizophrenia., Br J Psychiatry, 165, 695, 10.1192/bjp.165.5.695b · DOI
- 10.1176/appi.ps.51.2.216 · DOI · Paper page
- 10.1016/S0010-440X(98)90063-3 · DOI
- Haynes, 1980, Can simple clinical measurements detect patient non-compliance?, Hypertension, 2, 757, 10.1161/01.HYP.2.6.757 · DOI · Paper page
- Diaz, 2001, Use of the medication event monitoring system to estimate medication compliance in patients with schizophrenia., J Psychiatry Neurosci, 26, 325
- 10.1016/S0165-1781(96)03013-2 · doi:10.1016/s0165-1781(96)03013-2
- Sellwood, 1994, Demographic factors associated with extreme non-compliance in schizophrenia., Soc Psychiatry Psychiatr Epidemiol, 29, 172, 10.1007/BF00802014 · DOI
Cited by
Interventions for enhancing medication adherence
Nieuwlaat, R., Wilczynski, N., Navarro, T., Hobson, N., Jeffery, R., Keepanasseril, A., Agoritsas, T., Mistry, N., Iorio, A., Jack, S., et al. (2014) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd000011.pub4 · Cited by 2,945
Interventions for enhancing medication adherence
Haynes, R. B., Ackloo, E., Sahota, N., McDonald, H. P., & Yao, X. (2008) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd000011.pub3 · Cited by 1,244
Barnes, T. R., Drake, R., Paton, C., Cooper, S. J., Deakin, B., Ferrier, I. N., Gregory, C. J., Haddad, P. M., Howes, O. D., Jones, I., et al. (2020) · Journal of Psychopharmacology · doi:10.1177/0269881119889296 · Cited by 606
Nonadherence with antipsychotic medication in schizophrenia: challenges and management strategies
Haddad, P., Brain, C., & Scott, J. (2014) · Patient Related Outcome Measures · doi:10.2147/prom.s42735 · Cited by 585
Kane, J. M., Kishimoto, T., & Correll, C. U. (2013) · World Psychiatry · doi:10.1002/wps.20060 · Cited by 520
Metadata
- Authors
- O'Donnell, C., Donohoe, G., Sharkey, L., Owens, N., Migone, M., Harries, R., Kinsella, A., Larkin, C., & O'Callaghan, E.
- Venue
- BMJ
- Publisher
- BMJ
- Published
- 2003-10-09
- Volume
- 327
- Issue
- 7419
- Pages
- 834
- ISSN
- 0007-1447 (ISSN-L)
- 0959-8138
- 1468-5833
- OpenAlex
- W2019604513
- Cited by
- 219
- References
- 2
- FWCI
- 15.70
- Type
- journal article
- Language
- en
- Open access
- bronze
- Licence
- www.bmj.com/company/legal-information/terms-conditions/legal-information/tdm-licencepolicy (tdm)
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Compliance therapy: a randomised controlled trial in schizophrenia. https://app.cochat.ai/papers/10.1136/bmj.327.7419.834
- The paper
- O'Donnell, C., Donohoe, G., Sharkey, L., Owens, N., Migone, M., Harries, R., Kinsella, A., Larkin, C., & O'Callaghan, E. (2003). Compliance therapy: a randomised controlled trial in schizophrenia. BMJ. https://doi.org/10.1136/bmj.327.7419.834
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.